$3.690
-0.154 (-4.16%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de IRD por análisis de gráficos similares
Alphio's IRD stock price prediction model matches the current Opus Genetics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.70 (+0.35%). The 1-week path is $3.76 (+1.85%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Opus Genetics Inc?
Opus Genetics Inc (IRD) is a good buy right now due to its current price of $3.69, which is significantly lower than analyst price targets of $9 and $13, indicating substantial upside potential. The company's recent alignment with the FDA on its Phase 3 trial design for a gene therapy product is a strong positive catalyst, which could lead to increased investor interest. However, the main risk is the negative net income reported at -65,535,000 USD for Q1 2026, which highlights ongoing financial challenges.
IRD cerró en $3.69 el Friday, tras bajar -4.16%
Opus Genetics Inc (IRD) last closed at $3.69, losing -4.16%. These facts feed the 1-day and 1-week IRD price prediction above.
Factores de la previsión
Los factores de la previsión de Opus Genetics Inc (IRD) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de IRD, ordenadas por similitud.
Análisis de estacionalidad de IRD
Historically the probability of a positive August return for IRD is 31.75%. December offers the highest probability of a positive month at 51.16%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de IRD
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $1.40 | $1.68 | $2.14 | -54.43% |
| Sep 2026 | $1.41 | $1.60 | $2.04 | -56.70% |
| Oct 2026 | $1.36 | $1.62 | $2.10 | -56.22% |
| Nov 2026 | $1.12 | $1.63 | $1.91 | -55.72% |
| Dec 2026 | $0.82 | $1.26 | $1.53 | -65.93% |
En 2026, se proyecta que Opus Genetics Inc (IRD) oscile entre $0.82 y $2.14.
Previsión mensual de Opus Genetics Inc para 2026
En Aug de 2026, se proyecta que Opus Genetics Inc promedie $1.68, con un mínimo de $1.40 y un máximo de $2.14.
En Sep de 2026, se proyecta que Opus Genetics Inc promedie $1.60, con un mínimo de $1.41 y un máximo de $2.04.
En Oct de 2026, se proyecta que Opus Genetics Inc promedie $1.62, con un mínimo de $1.36 y un máximo de $2.10.
En Nov de 2026, se proyecta que Opus Genetics Inc promedie $1.63, con un mínimo de $1.12 y un máximo de $1.91.
En Dec de 2026, se proyecta que Opus Genetics Inc promedie $1.26, con un mínimo de $0.82 y un máximo de $1.53.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.